BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 30482582)

  • 1. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
    Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
    World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological Evaluation of a Fluorescent-Imaging Agent for Medullary Thyroid Cancer in an Orthotopic Model.
    Rossfeld KK; Justiniano SE; Ding H; Gong L; Kothandaraman S; Sawant D; Saji M; Wright CL; Kirschner LS; Ringel MD; Tweedle MF; Phay JE
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3268-3277. PubMed ID: 28591772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply to Letter to the Editor regarding "Decreased utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer".
    Maniakas A; Hu MI; Gunn GB; Zafereo M
    Head Neck; 2024 Jul; 46(7):1848-1849. PubMed ID: 38646970
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for postoperative radiotherapy in medullary thyroid cancer.
    Rowell NP
    Head Neck; 2024 Jul; 46(7):1846-1847. PubMed ID: 38646954
    [No Abstract]   [Full Text] [Related]  

  • 5. Precision Thyroidectomy in Sporadic Medullary Thyroid Cancer.
    Shaha AR; Davies L; Tuttle RM
    JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):215-216. PubMed ID: 38270970
    [No Abstract]   [Full Text] [Related]  

  • 6. Coexistence of medullary thyroid carcinoma and gastric carcinoma: A case report and literature review.
    Gan XX; Feng JH; Cai WS; Xu B
    Asian J Surg; 2024 Apr; 47(4):1829-1830. PubMed ID: 38160156
    [No Abstract]   [Full Text] [Related]  

  • 7. Surgical De-Escalation in Medullary Thyroid Cancer: A Commentary.
    Ginzberg SP; Krumeich LN
    Oncologist; 2023 Dec; 28(12):1017-1019. PubMed ID: 37769340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medullary thyroid carcinoma with extremely rare presentation in a child: Considerations for management.
    Moreddu E; Guerin C; Nicollas R; Aschero A; Essamet W; Min V; Coze C
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30823. PubMed ID: 38189596
    [No Abstract]   [Full Text] [Related]  

  • 9. Endometrial neuroendocrine carcinoma: An analysis for 5 cases and literature review.
    Pei KG; Zhang JW
    Asian J Surg; 2023 Dec; 46(12):5942-5943. PubMed ID: 37696699
    [No Abstract]   [Full Text] [Related]  

  • 10. Calcitonin-negative medullary thyroid carcinoma: the 'triple-negative' phenotype.
    Murphy DC; Johnson SJ; Aspinall S
    Ann R Coll Surg Engl; 2020 Mar; 102(3):e63-e66. PubMed ID: 31841033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma?
    Gambardella C; Offi C; Patrone R; Clarizia G; Mauriello C; Tartaglia E; Di Capua F; Di Martino S; Romano RM; Fiore L; Conzo A; Conzo G; Docimo G
    BMC Endocr Disord; 2019 May; 19(Suppl 1):45. PubMed ID: 31142313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Jin LX; Moley JF
    Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F-18-Dopa Positron Emission Tomography/Computed Tomography Is More Sensitive Than Whole-Body Magnetic Resonance Imaging for the Localization of Persistent/Recurrent Disease of Medullary Thyroid Cancer Patients.
    Terroir M; Caramella C; Borget I; Bidault S; Dromain C; El Farsaoui K; Deandreis D; Grimaldi S; Lumbroso J; Berdelou A; Hadoux J; Hescot S; Hartl D; Baudin E; Schlumberger M; Leboulleux S
    Thyroid; 2019 Oct; 29(10):1457-1464. PubMed ID: 31530235
    [No Abstract]   [Full Text] [Related]  

  • 14. What Is the Extent of Neck Dissection in Medullary Thyroid Carcinoma?
    Asarkar A; Chang BA; Nathan CO
    Laryngoscope; 2021 Mar; 131(3):458-459. PubMed ID: 32311764
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent disease and recurrence in medullary thyroid carcinoma: A case series.
    Tejera Hernández AA; Gutiérrez Giner MI; Rocca Cárdenas JC; Rodríguez Rodríguez F; Hernández Hernández JR
    Cir Esp (Engl Ed); 2019 Apr; 97(4):234-237. PubMed ID: 30482582
    [No Abstract]   [Full Text] [Related]  

  • 17. Timing and extension of lymphadenectomy in medullary thyroid carcinoma: A case series from a single institution.
    Polistena A; Sanguinetti A; Lucchini R; Galasse S; Monacelli M; Avenia S; Boccolini A; Johnson LB; Avenia N
    Int J Surg; 2017 May; 41 Suppl 1():S70-S74. PubMed ID: 28506418
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.